Close
Join us at the 32nd International Symposium on ALS/MND

Join us at the 32nd International Symposium on ALS/MND

Reading Time: 3 minutes

Welcome to the final blog, number 22, in our Symposium Blogathon – counting down to the 32nd International Symposium on ALS/MND. If you’ve been here since blog number 1, published all the way back at the beginning of November, then well done! I hope you’ve found the blogs interesting and informative. If this is the first one you’ve read, you’ve got some catching up to do – you can find a full list of all the blogs published in the blogathon here.

A quick reminder of what the Symposium is all about. The International Symposium on ALS/MND is the premier event in the ALS/MND calendar. It is the biggest conference of its kind and, last year, attracted over 1,800 delegates from 48 countries, including many people affected by MND.

A highlight of the Symposium are the presentations given by our plenary speakers – experts in their respective fields who provide an overview of a variety of topics across the ALS/MND research and clinical management spectrum. This year we have thirteen plenary speakers, including Steve Gleason, a former NFL player in the USA who is now living with MND.

As well as our plenary speakers we have a further 15 oral presentations and close to 350 poster presentations. Abstracts, which are a brief scientific summary of work, for all presentations can be found here.

Registration for the Symposium closes at 11.59pm on Wednesday 1 December so don’t miss out and register now. Registration is just £60 and gives you access to all of this:

  • The virtual platform, viewable on laptop, desktop, mobile and tablet,
  • The full programme of plenary and oral presentations with live Q&As, and live poster sessions.
  • The ePoster hall – explore all the posters at this year’s event on demand, watch ‘lightning explainer’ videos to support content, and talk to authors.
  • The Sponsor/Exhibitor Hall – browse and explore various resources with the opportunity to talk with sponsors and exhibitors in real time or schedule meetings.
  • Meeting hub – meet and connect with other attendees to chat, call and schedule meetings.
  • The mobile app – containing lots of useful information, networking, agendas, exhibitor searches, messaging and notifications.
  • Gamification – earn points as you take part in various aspects of the virtual event to win prizes each day.
  • On-demand access to content for at least 30 days after the event.

People living with MND, their carers and families, are at the heart of everything we do, and our reason for organising the Symposium every year. Hosting the event on a virtual platform presents the perfect opportunity for the general public to attend and we would really like to see as many of you as possible at the event this year. All aspects of MND research and clinical care and management are covered, and this is your opportunity to ask those burning questions, chat with presenters and meet like-minded people in both the research and wider MND community.

Stay informed

You can find the full programme of speakers and poster sessions here.

Abstract books for all presentations are available here.

Find out more about our plenary speakers here.

If you have come across this blog through the Symposium website, or a general search, please subscribe (top right-hand corner of the page) and you’ll be notified every time we upload a new article.

You can follow our research account on Twitter. We tweet about up to the minute research and will be tweeting throughout the Symposium – #alsmndsymp #drivingmndresearch

Take a look at the schedule of blogs and catch up with any you have missed.

And remember, you can listen to talks live, take part in the Q&As and visit the live poster sessions by registering for the International Symposium now.

Once again, we hope you have enjoyed the Symposium Blogathon and we look forward to welcoming you to the 32nd International Symposium on ALS/MND on Tuesday 7 December at 2pm GMT.

Leave a Reply

Your email address will not be published. Required fields are marked *